| Name | Title | Contact Details |
|---|
The mission of H3 Consulting Group is to supply our valued customers with the following top quality services: Risk Management, Security Consulting, Rescue & Evacuation, Executive Protective Services, (PSD), Maritime Security, Executive Services & Logistics, Hostage Negotiation, Intelligence & Counterintelligence, Security in High Risk Areas, Corporate Security, Security Technoloies, Civil Affairs, Dignitary Protective Services, Tactical Training and much more. H3 Group is registered in the CCR (Central Contractor Registration) as supplier of services and products for the U.S. Government and for NATO defense administrations . Our capabilities include, but are not limited to, rental of luxury cars (limos & SUVs) with security drivers, executive aircraft, helicopters, yachts with specialized crews, research & reservation of five-star locations (villas, resorts, hotels), interpreter services and temporary manager assistants. We are mission capable around the globe including Non Permissive environments. H3 Consulting Group is a one stop shop able to provide security services and solutions to governments, corporates and prominent individuals worldwide.
C2 Company is a San Mateo, CA-based company in the Business Services sector.
CW Agencies, Inc. is a Vancouver, BC-based company in the Business Services sector.
Apellis Pharmaceuticals is a global biopharmaceutical company based in Waltham, Massachusetts. The company is focused on developing innovative therapies that target the complement system, a crucial part of the immune system. Apellis aims to create life-changing treatments for various debilitating diseases through its commitment to scientific research and patient care. The company has a diverse pipeline of products, including EMPAVELI, which is approved for treating paroxysmal nocturnal hemoglobinuria and is being investigated for other conditions. SYFOVRE is in development for geographic atrophy, along with a combination therapy involving APL-APL-3007. Apellis is also exploring RNA therapies and gene-edited treatments for multiple therapeutic areas. With a global presence in countries such as the US, Canada, and several European nations, Apellis serves patients and healthcare providers affected by diseases related to the complement system. The company reported approximately $709 million in U.S. net product revenues for the full year 2024, reflecting its strong market position and commitment to advancing its therapeutic offerings.
Transmarine Navigation Corporation is a Long Beach, CA-based company in the Business Services sector.